Chapman RW - Search Results

1

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.

Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, Andreassen OA, Weersma RK, Weismüller TJ, Eksteen B, Invernizzi P, Hirschfield GM, Gotthardt DN, Pares A, Ellinghaus D, Shah T, Juran BD, Milkiewicz P, Rust C, Schramm C, Müller T, Srivastava B, Dalekos G, Nöthen MM, Herms S, Winkelmann J, Mitrovic M, Braun F, Ponsioen CY, Croucher PJ, Sterneck M, Teufel A, Mason AL, Saarela J, Leppa V, Dorfman R, Alvaro D, Floreani A, Onengut-Gumuscu S, Rich SS, Thompson WK, Schork AJ, Næss S, Thomsen I, Mayr G, König IR, Hveem K, Cleynen I, Gutierrez-Achury J, Ricaño-Ponce I, van Heel D, Björnsson E, Sandford RN, Durie PR, Melum E, Vatn MH, Silverberg MS, Duerr RH, Padyukov L, Brand S, Sans M, Annese V, Achkar JP, Boberg KM, Marschall HU, Chazouillères O, Bowlus CL, Wijmenga C, Schrumpf E, Vermeire S, Albrecht M; UK-PSCSC Consortium; Rioux JD, Alexander G, Bergquist A, Cho J, Schreiber S, Manns MP, Färkkilä M, Dale AM, Chapman RW, Lazaridis KN; International PSC Study Group; Franke A, Anderson CA, Karlsen TH; International IBD Genetics Consortium. Liu JZ, et al. Among authors: chapman rw. Nat Genet. 2013 Jun;45(6):670-5. doi: 10.1038/ng.2616. Epub 2013 Apr 21. Nat Genet. 2013. PMID: 23603763 Free PMC article.

2

Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques.

Bansi DS, Bauducci M, Bergqvist A, Boberg K, Broome U, Chapman R, Fleming K, Jorgensen R, Lindor K, Rosina F, Schrumpf E. Bansi DS, et al. Eur J Gastroenterol Hepatol. 1997 Jun;9(6):575-80. doi: 10.1097/00042737-199706000-00005. Eur J Gastroenterol Hepatol. 1997. PMID: 9222729 Clinical Trial.

3

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations.

Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome U, Caballeria L, Ciusani E, Chapman R, Ercilla G, Fausa O, Knutsen I, Pares A, Rosina F, Olerup O, Thorsby E, Schrumpf E. Spurkland A, et al. Tissue Antigens. 1999 May;53(5):459-69. doi: 10.1034/j.1399-0039.1999.530502.x. Tissue Antigens. 1999. PMID: 10372541

4

Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism.

Norris S, Kondeatis E, Collins R, Satsangi J, Clare M, Chapman R, Stephens H, Harrison P, Vaughan R, Donaldson P. Norris S, et al. Gastroenterology. 2001 May;120(6):1475-82. doi: 10.1053/gast.2001.24041. Gastroenterology. 2001. PMID: 11313318

5

The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis.

Boberg KM, Spurkland A, Rocca G, Egeland T, Saarinen S, Mitchell S, Broomé U, Chapman R, Olerup O, Pares A, Rosina F, Schrumpf E. Boberg KM, et al. Scand J Gastroenterol. 2001 Aug;36(8):886-90. doi: 10.1080/003655201750313441. Scand J Gastroenterol. 2001. PMID: 11495087

6

Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis.

Boberg KM, Rocca G, Egeland T, Bergquist A, Broomé U, Caballeria L, Chapman R, Hultcrantz R, Mitchell S, Pares A, Rosina F, Schrumpf E. Boberg KM, et al. Hepatology. 2002 Mar;35(3):652-7. doi: 10.1053/jhep.2002.31872. Hepatology. 2002. PMID: 11870380

7

Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.

Boberg KM, Bergquist A, Mitchell S, Pares A, Rosina F, Broomé U, Chapman R, Fausa O, Egeland T, Rocca G, Schrumpf E. Boberg KM, et al. Scand J Gastroenterol. 2002 Oct;37(10):1205-11. doi: 10.1080/003655202760373434. Scand J Gastroenterol. 2002. PMID: 12408527

8

Sclerosing cholangitis.

Björnsson E, Chapman RW. Björnsson E, et al. Among authors: chapman rw. Curr Opin Gastroenterol. 2003 May;19(3):270-5. doi: 10.1097/00001574-200305000-00011. Curr Opin Gastroenterol. 2003. PMID: 15703568

9

Sclerosing cholangitis.

MacFaul GR, Chapman RW. MacFaul GR, et al. Among authors: chapman rw. Curr Opin Gastroenterol. 2005 May;21(3):348-53. doi: 10.1097/01.mog.0000155359.43763.cc. Curr Opin Gastroenterol. 2005. PMID: 15818157 Review.

10

High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective.

Cullen SN, Rust C, Fleming K, Edwards C, Beuers U, Chapman RW. Cullen SN, et al. Among authors: chapman rw. J Hepatol. 2008 May;48(5):792-800. doi: 10.1016/j.jhep.2007.12.023. Epub 2008 Feb 14. J Hepatol. 2008. PMID: 18314215 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

379 results

Search Page